GILD
Gilead Sciences, Inc (GILD) Q4 2025 Earnings Call Transcript
Gilead Sciences, Inc (NASDAQ: GILD) Q4 2025 Earnings Call dated Feb. 10, 2026 Corporate Participants: Jacquie Ross — Senior Vice…
Gilead Sciences, Inc (GILD) Gilead Foundation Awards $12 Million to Empower Community Health Workers and Expand HIV Prevention Initiatives Across 14 States and the District of Columbia
Gilead Sciences, Inc (NASDAQ: GILD) FY 2026 Other Release
Gilead Sciences, Inc (GILD) Sec Form 10K
Gilead Sciences, Inc (NASDAQ: GILD) Sec Form 10K
Gilead Sciences, Inc (GILD) Gilead’s Single-Tablet Regimen of Bictegravir and Lenacapavir Maintained Virological Suppression in People With HIV Who Switched Antiretroviral Therapy
Gilead Sciences, Inc (NASDAQ: GILD) FY 2026 Other Release
Gilead Sciences, Inc (GILD) Sec Form 8K
Gilead Sciences, Inc (NASDAQ: GILD) Sec Form 8K
Gilead Sciences, Inc (GILD) Barclays Annual Global Healthcare Conference
Gilead Sciences, Inc (NASDAQ: GILD) FY 2026 Corporate Conference
Gilead Sciences, Inc (GILD) Leerink Partners Global Healthcare Conference
Gilead Sciences, Inc (NASDAQ: GILD) FY 2026 Corporate Conference
Gilead Sciences, Inc (GILD) TD Cowen Annual Health Care Conference
Gilead Sciences, Inc (NASDAQ: GILD) FY 2026 Corporate Conference
S&P 500 Gains as Risk-On Rotation Sends Energy Up 1.84%, Utilities Down 1.68%
S&P 500 gains 0.52% as energy surges 1.84% and tech adds 1.34%, while utilities tumble 1.68% in risk-on rotation.
Gilead Sciences, Inc (GILD) Gilead to Present New HIV Treatment and Prevention Data at CROI 2026, With a Focus on Expanding Options
Gilead Sciences, Inc (NASDAQ: GILD) FY 2026 Other Release